Ontology highlight
ABSTRACT: Background
Fecal calprotectin (Fcal) is a noninvasive, inexpensive biomarker of disease activity. However, patient compliance with this test is variable and incompletely described. We assessed compliance rates with Fcal tests and identified factors associated with noncompliance.Methods
A retrospective chart review of patients with inflammatory bowel disease (IBD) who had a Fcal test ordered through our center between August 2021 and December 2021 was conducted. Demographic, clinical, disease, and test-related information were recorded. Patients with incomplete Fcal orders were sent a survey to better understand their reasons for noncompliance. Simple statistical analysis and and multivariable logistic regression modeling were performed.Results
Of 303 patients, 165 (
SUBMITTER: Fenton D
PROVIDER: S-EPMC9802166 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature